BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35274752)

  • 1. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
    Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T
    Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACCURACY OF PLASMA FREE METANEPHRINES IN THE DIAGNOSIS OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chen Y; Xiao H; Zhou X; Huang X; Li Y; Xiao H; Cao X
    Endocr Pract; 2017 Oct; 23(10):1169-1177. PubMed ID: 28704098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Goupil R; Fountoulakis S; Gordon RD; Stowasser M
    J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
    Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ
    J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between systolic blood pressure reduction during clonidine suppression testing and the decrease in plasma catecholamines and metanephrines.
    Golani T; Fishman B; Sharabi Y; Olswang-Kutz Y; Leibowitz A; Grossman E; Shlomai G
    J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1924-1931. PubMed ID: 32882089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
    Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
    J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
    Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability and reference intervals of spot urinary fractionated metanephrines and methoxytyramine by tandem mass spectrometry as a screening method for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Cong H; Zhang W; Shi X; Dai S; Zhou Z
    Endocrine; 2020 Jul; 69(1):188-195. PubMed ID: 32222878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Salivary Metanephrines in Pheochromocytomas and Paragangliomas.
    Eijkelenkamp K; Osinga TE; van Faassen M; Kema IP; Kerstens MN; Pacak K; Sluiter WJ; Links TP; van der Horst-Schrivers ANA
    Clin Chem; 2021 Aug; 67(8):1090-1097. PubMed ID: 34096581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
    Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
    Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
    Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT; Frystyk J; Poulsen PL
    Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
    Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
    Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea.
    King TFJ; Mok Y; Dacay LM; Wong HS; Hsu PP; Tan A; Wong KM; Saffari SE; Lenders JWM; Puar TH
    J Clin Endocrinol Metab; 2024 Feb; 109(3):844-851. PubMed ID: 37721483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
    Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
    Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
    Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
    Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma.
    Lagerstedt SA; O'Kane DJ; Singh RJ
    Clin Chem; 2004 Mar; 50(3):603-11. PubMed ID: 14726465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
    Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
    Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.